SG141206A1 - Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid - Google Patents

Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid

Info

Publication number
SG141206A1
SG141206A1 SG9904360-6A SG1999004360A SG141206A1 SG 141206 A1 SG141206 A1 SG 141206A1 SG 1999004360 A SG1999004360 A SG 1999004360A SG 141206 A1 SG141206 A1 SG 141206A1
Authority
SG
Singapore
Prior art keywords
alpha
treating
salt
composition
carboxylic acid
Prior art date
Application number
SG9904360-6A
Other languages
English (en)
Inventor
Prakash Parab
Robert Lavker
James Leyden
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SG141206A1 publication Critical patent/SG141206A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
SG9904360-6A 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid SG141206A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67157791A 1991-03-19 1991-03-19

Publications (1)

Publication Number Publication Date
SG141206A1 true SG141206A1 (en) 2008-04-28

Family

ID=24695083

Family Applications (2)

Application Number Title Priority Date Filing Date
SG9603463A SG79901A1 (en) 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid
SG9904360-6A SG141206A1 (en) 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG9603463A SG79901A1 (en) 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid

Country Status (15)

Country Link
US (2) US5254343A (de)
EP (1) EP0504862B1 (de)
JP (1) JP3504279B2 (de)
KR (1) KR100193993B1 (de)
AT (1) ATE141050T1 (de)
AU (1) AU655005B2 (de)
CA (1) CA2063127C (de)
DE (1) DE69212610T2 (de)
DK (1) DK0504862T3 (de)
ES (1) ES2090390T3 (de)
GR (1) GR3020779T3 (de)
IE (1) IE920859A1 (de)
SG (2) SG79901A1 (de)
TW (1) TW208658B (de)
ZA (1) ZA921821B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5683705A (en) * 1996-03-29 1997-11-04 Estee Lauder, Inc. Sulfur-based amides and bis-amides useful against skin disorders
US5993792A (en) * 1997-11-13 1999-11-30 Tiro Industries Incorporated System for customized hair products containing surfactants
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
WO2002069977A1 (en) 2001-03-01 2002-09-12 Hollis-Eden Pharmaceuticals, Inc. Use of certain steroids for treatment of blood cell deficiencies
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
EP2298315A1 (de) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutische Behandlungsmethoden
AU2005330504B2 (en) 2004-09-29 2010-10-28 Harbor Biosciences, Inc. Steroid analogs and characterization and treatment methods
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
DE102014209988A1 (de) * 2014-05-26 2015-11-26 Deb Ip Limited Aluminiumlactat als Hautschutzkomponente

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4380549A (en) * 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
PH13782A (en) * 1976-09-07 1980-09-26 E Scott Therapeutic treatment of dry skin
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US4937068A (en) * 1988-10-31 1990-06-26 Jim Baral Sun tanning medication and treatment
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy

Also Published As

Publication number Publication date
KR920017648A (ko) 1992-10-21
CA2063127C (en) 2002-01-29
ATE141050T1 (de) 1996-08-15
HK1004532A1 (en) 1998-11-27
AU655005B2 (en) 1994-12-01
EP0504862B1 (de) 1996-08-07
GR3020779T3 (en) 1996-11-30
DK0504862T3 (da) 1996-09-02
US5254343A (en) 1993-10-19
ZA921821B (en) 1993-01-27
IE920859A1 (en) 1992-09-23
AU1295592A (en) 1992-09-24
KR100193993B1 (ko) 1999-06-15
ES2090390T3 (es) 1996-10-16
JP3504279B2 (ja) 2004-03-08
TW208658B (de) 1993-07-01
SG79901A1 (en) 2001-04-17
JPH05117144A (ja) 1993-05-14
EP0504862A1 (de) 1992-09-23
DE69212610D1 (de) 1996-09-12
DE69212610T2 (de) 1997-03-27
US5807600A (en) 1998-09-15
CA2063127A1 (en) 1992-09-20

Similar Documents

Publication Publication Date Title
SG141206A1 (en) Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid
CA2083390A1 (en) Polyaspartic acid as a calcium sulfate and a barium sulfate inhibitor
AU1516588A (en) Steroid 5-alpha-reductase inhibitors
AU6094096A (en) Use of gamma-hydroxybutyrate for the stimulation of sleep-re lated growth hormone secretion
EP0663823A4 (de) Angiogenesehemmung mit synthetischen matrix-metalloproteaseinhibitoren.
EP0615458A4 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen.
EP0604641A4 (de) Zusammensetzung, die aminderivate oder aminverwandte derivate der benzoesäure enthält, und ihre verwendung einschliesslich der behandlung von entzündlichen erkrankungen.
MY107068A (en) Low volatility salts.
UA8025A1 (uk) Спосіб отримання антибактеріального розчину
HU9501799D0 (en) Substituted triols
ZA923279B (en) Substituted carboxylic acid derivatives
SG50453A1 (en) Use of retinoids for reversing glucocorticoid induced skin atrophy
HU9202817D0 (en) Bicyclical carboxylic acid derivatives
HU9902668D0 (en) Compounds with growth hormone releasing properties
AU2133192A (en) Oligoquinolinium metal oxide salts as sulfur corrosion inhibitors
TW221431B (de)
IL72004A (en) Process for debromination of bromopenicillanic acids and derivatives
ZA948631B (en) 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
EP0470431A3 (en) Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer
GB9303500D0 (en) Carboxylic acid esters fo hydroxyphenylalkanols as stabilisers
AU570991B2 (en) Substituted imidazolinyl benzoic acids
ZA851991B (en) 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
NZ240392A (en) Calcium borate/amino carboxylate corrosion inhibitors: coating formulations
IL105527A0 (en) 17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors
FI914260A7 (fi) Monokarboksyylihappoestereitä ja niiden avulla stabiloitu koostumus